Phil-Ok Koh was not included as an author in the published article. The corrected Author Contributions Statement appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Author contributions
FA and GL managed the experimental work. FA and GL performed surgery, western blot, morphological experiments; performed data analysis. AZ, P-OK, MA, LA, FL, TL, XY, YJ and SL supported the study, designed study, and wrote the manuscript. YJ and SL are the corresponding authors, reviewed and approved the manuscript and held all the responsibilities related to this manuscript. All authors reviewed and approved the manuscript.
Summary
Keywords
melatonin, ischemic stroke, NMDA receptor, AMPA receptor, PI3K/AKT/GSK3 pathway
Citation
Shah FA, Liu G, Al Kury LT, Zeb A, Koh P-O, Abbas M, Li T, Yang X, Liu F, Jiang Y and Li S (2019) Corrigendum: Melatonin Protects MCAO-Induced Neuronal Loss via NR2A Mediated Prosurvival Pathways. Front. Pharmacol. 10:702. doi: 10.3389/fphar.2019.00702
Received
16 May 2019
Accepted
30 May 2019
Published
21 June 2019
Volume
10 - 2019
Edited and reviewed by
Frontiers in Pharmacology Editorial Office, Frontiers Media SA, Switzerland
Updates
Copyright
© 2019 Shah, Liu, Al Kury, Zeb, Koh, Abbas, Li, Yang, Liu, Jiang and Li.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yuhua Jiang, jiangyuhua@sdu.edu.cn; Shupeng Li, lisp@pkusz.edu.cn, lishupeng76@gmail.com
†These authors have contributed equally to this work.
This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.